Screen Shot 2015-11-18 at 4.55.47 PM

MLP Interest Rates: As yield-based investments, MLPs carry interest rate risk and may underperform in rising interest rate environments. Additionally, when investors have heightened fears about the economy, the risk spread between MLPs and competing investment options can widen, which may have an adverse effect on the stock price of MLPs. Rising interest rates may increase the potential cost of MLPs financing projects or cost of operations, and may affect the demand for MLP investments, either of which may result in lower performance by or distributions from the Fund’s MLP investments.


Screen Shot 2015-11-18 at 4.55.47 PM

Made the trade. Just swapped IBB for an equal position in XBI. In the process closed the IBB April, and opened an XBI May.

This was done for the reason that XBI trades at circa $55 and IBB at circa $260. XBI is also a SPDR product, not that it makes much practical difference.

Screen Shot 2015-11-18 at 4.55.47 PM

IBB is my long-term core position that I trade around. I collect circa 1% return/month on this core position, irrespective of capital fluctuations.

IBB had a bit of a move higher this week. There is a bit of chatter that this might be the end of the down trend and the start of a move higher, but, who knows.

XIB which is another biotech ETF actually has a higher dividend and a lower priced unit. I’m tempted to flippe-floppe into XIB as it suits my trading style better than a high priced stock, so tomorrow I may swap, even though I’ll incur brokerage charges all around.


Swapping these positions one for t’other




I had two big winners off of earnings today:









I’ve been doing some selling this morning: EWP; EGPT; EWI; and EWG. All are up 50% or greater. Time to bank some profit. Even with Drahgi and the European rates going negative [which should work for stocks] it is always prudent to take a little off the table when you have it…just in case you’re still holding if they don’t [that’s the time to buy].


Next Page »